Rat Germline Gene Editing Products and Services
大鼠种系基因编辑产品和服务
基本信息
- 批准号:9409628
- 负责人:
- 金额:$ 17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAllelesAllogenicAnimal ModelAnimalsBenchmarkingBiological AssayBiological ProcessBiomedical ResearchBusinessesCatalogsCell Culture TechniquesCustomEventFertilityFreezingGene TargetingGenesGeneticGenetic EngineeringGenetic ModelsGenomic DNAGenomicsHealthHumanInbreedingIndividualMeasuresMethodsModelingModificationOrganismPhaseProductionProtocols documentationQuality ControlRat StrainsRattusResearch PersonnelSavingsScientistSeedsServicesSmall Business Innovation Research GrantStem cellsTechnologyTestisTimeTransplantationclinically relevantcostdesigndigitalgene functiongenetic selectiongermline stem cellsmalemutantnovelprognosticsperm celltransmission processvector
项目摘要
Summary
Direct germline editing in donor spermatogonial stem cells will streamline production of genetically
modified model organisms and provide unprecedented quality control to accurately predict germline
transmission rates for individually selected, or multiple, co-selected targeted alleles.
GenomeDesigns' direct germline editing technologies will transform the custom rat model market by
providing the broadest range of targeted genomic DNA insertion sizes available in the broadest range
of tractable rat genetic backgrounds. Here, we propose three specific aims to produce frozen
spermatogonial stocks that can be used as germline vectors to build custom designed, genetically
modified rat models. In Specific Aim 1, spermatogonial stocks derived from up to 12 different popular
outbred and inbred rat genetic backgrounds will be generated to seed GenomeDesigns with the most
comprehensive catalogue of custom designable rat models. In Specific Aim 2, precise spermatogonial
gene targeting efficiencies will be measured by droplet digital PCR (ddPCR) to guide animal
production protocols, benefiting individual customers and GenomeDesigns. We will apply ddPCR to
project real production cost and time savings received by co-transmitting, co-selected gene targeting
events from an individual germline, or by polyclonal rat production where distinct spermatogonial lines
are pooled and transplanted into a single recipient rat. In Specific Aim 3, developing recipient males
compatible with diverse donor spermatogonial strains will build an unmatched portfolio of biomedically
relevant rat strains amenable to genetic engineering. By completing Phase I Specific Aims,
GenomeDesigns will provide proof-of-concept for building a genetically diverse catalogue of
spermatogonial stocks that uniquely enable strong genetic selection for precise, sexually
transmittable, genomic modifications directly in the rat germline.
Benchmarks for this Phase I SBIR project are:
1) Significantly expand spermatogonial gene targeting services into new rat genetic backgrounds
2) Establish ddPCR as prognostic for germline transmission of co-selected gene targeting events
3) Produce recipient rat models for diverse donor rat spermatogonial genetic backgrounds
总结
供体精原干细胞中的直接生殖系编辑将简化遗传学上的生产。
改良的模式生物,并提供前所未有的质量控制,以准确预测种系
单独选择的或多个共同选择的靶向等位基因的传输率。
GenomeDesigns的直接生殖系编辑技术将通过以下方式改变定制大鼠模型市场:
提供最宽范围的靶向基因组DNA插入大小,
温顺的老鼠遗传背景在这里,我们提出了三个具体目标,以生产冷冻
精原细胞储备,可以用作生殖系载体,以建立定制设计的,遗传
改良大鼠模型。在特定目标1中,精原细胞来源于多达12种不同的流行
将产生远系繁殖和近交大鼠遗传背景,以播种具有最多遗传背景的基因组设计。
定制可设计大鼠模型的全面目录。在特定目标2中,精原细胞
将通过液滴数字PCR(ddPCR)测量基因靶向效率,以指导动物
生产协议,使个人客户和GenomeDesigns受益。我们将ddPCR应用于
通过共同传播、共同选择的基因靶向,节省项目真实的生产成本和时间
事件,或通过多克隆大鼠生产,其中不同的精原细胞系
合并并移植到单个受体大鼠中。在具体目标3中,发育中的受体男性
与不同的供体精原细胞株兼容将建立无与伦比的生物医学产品组合
适合基因工程的相关大鼠品系。通过完成第一阶段的具体目标,
GenomeDesigns将为建立一个遗传多样性的基因目录提供概念验证。
精原种群,独特地使强大的遗传选择,
直接在大鼠生殖系中进行可传递的基因组修饰。
第一阶段SBIR项目的基准是:
1)将精原细胞基因靶向服务显著扩展到新的大鼠遗传背景
2)建立ddPCR作为共选择基因靶向事件生殖系传播的预后
3)建立不同供鼠精原细胞遗传背景的受体大鼠模型
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
F. Kent Hamra其他文献
F. Kent Hamra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('F. Kent Hamra', 18)}}的其他基金
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
- 批准号:
10490286 - 财政年份:2021
- 资助金额:
$ 17万 - 项目类别:
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
- 批准号:
10307940 - 财政年份:2021
- 资助金额:
$ 17万 - 项目类别:
Development/Validation of Rete Testis Microcannulation for the Assessment of Novel Chemical Scaffolds That Penetrate the Blood Testis Barrier
睾丸网微插管的开发/验证,用于评估穿透血睾屏障的新型化学支架
- 批准号:
10924597 - 财政年份:2021
- 资助金额:
$ 17万 - 项目类别:
Sperm Stem Cell Libraries for Biological Research
用于生物学研究的精子干细胞文库
- 批准号:
8687761 - 财政年份:2011
- 资助金额:
$ 17万 - 项目类别:
Sperm Stem Cell Libraries for Biological Research
用于生物学研究的精子干细胞文库
- 批准号:
8487476 - 财政年份:2011
- 资助金额:
$ 17万 - 项目类别:
Sperm Stem Cell Libraries for Biological Research
用于生物学研究的精子干细胞文库
- 批准号:
8150034 - 财政年份:2011
- 资助金额:
$ 17万 - 项目类别:
Sperm Stem Cell Libraries for Biological Research
用于生物学研究的精子干细胞文库
- 批准号:
8298130 - 财政年份:2011
- 资助金额:
$ 17万 - 项目类别:
Biology of the ErbB Gene Family in Spermatogonial Development
ErbB 基因家族在精原细胞发育中的生物学
- 批准号:
7937725 - 财政年份:2009
- 资助金额:
$ 17万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 17万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 17万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 17万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 17万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 17万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 17万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 17万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 17万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 17万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 17万 - 项目类别: